A tradition of making
medicines the careful way.
The pharmacy on Bridge Street opened in 1949. Michael McLoughlin grew up over it.
He went on to spend fifty years as a pharmacist and master compounder, building an independent pharmacy chain and preparing formulations by hand for people he knew by name.
Working with the same ingredients across decades, he saw a relationship between them that nobody had developed into a protected commercial formulation. So he developed it: a highly novel, non-steroidal, antibiotic-free wound-care formulation, protected by a granted US patent.
The timing was not an accident. Antimicrobial resistance is pushing clinicians and patients toward alternatives to antibiotic-based approaches, and the long-term effects of repeated steroid use have made the same category scramble for alternatives. Demand is moving toward exactly the kind of formulation he spent fifty years arriving at.
We are building a portfolio around it: skin recovery, advanced wound care, and regulated medicines for human and veterinary use. That's where the Epitheal story, and the future of skin recovery, begins.
Meet the team
